Tawfeeq Shekh-Ahmad Selected Research

valnoctamide

1/2017	A randomized, double-blind, placebo- and risperidone-controlled study on valnoctamide for acute mania.
8/2015	The potential of sec-butylpropylacetamide (SPD) and valnoctamide and their individual stereoisomers in status epilepticus.
2/2014	Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential.
9/2013	Valnoctamide and sec-butyl-propylacetamide (SPD) for acute seizures and status epilepticus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tawfeeq Shekh-Ahmad Research Topics

Disease

14	Status Epilepticus (Complex Partial Status Epilepticus) 10/2021 - 01/2012
10	Epilepsy (Aura) 10/2021 - 01/2012
8	Seizures (Absence Seizure) 10/2020 - 01/2012
4	Neural Tube Defects (Exencephaly) 08/2015 - 02/2014
2	Temporal Lobe Epilepsy 10/2021 - 01/2018
2	Disease Progression 01/2019 - 07/2017
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2017 - 09/2013
2	Mania (Manias) 01/2017 - 02/2014
1	Brain Diseases (Brain Disorder) 10/2021
1	Drug Resistant Epilepsy 01/2018
1	Hippocampal Sclerosis 01/2018
1	Atrophy 01/2018
1	Congenital Abnormalities (Deformity) 01/2017
1	Sudden Infant Death (SID) 05/2015
1	Poisoning 12/2014
1	Inflammation (Inflammations) 10/2013
1	Hepatoblastoma 10/2013
1	Hypersensitivity (Allergy) 10/2013
1	Neuralgia (Stump Neuralgia) 09/2013

Drug/Important Bio-Agent (IBA)

7	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 01/2012
5	Pilocarpine (Ocusert)FDA LinkGeneric 01/2016 - 09/2013
5	sec-butyl-propylacetamideIBA 01/2016 - 08/2013
4	Valproic Acid (Depakote)FDA LinkGeneric 01/2017 - 08/2013
4	valnoctamideIBA 01/2017 - 09/2013
4	SomanIBA 08/2015 - 01/2012
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020 - 01/2018
3	OrganophosphatesIBA 01/2016 - 01/2012
3	TeratogensIBA 05/2015 - 02/2014
3	Pentylenetetrazole (Metrazol)IBA 12/2014 - 01/2012
2	AntioxidantsIBA 10/2021 - 01/2019
2	Kainic Acid (Kainate)IBA 10/2021 - 01/2018
2	Neuroprotective AgentsIBA 10/2021 - 01/2018
2	Drug CombinationsIBA 01/2019 - 07/2017
2	Pharmaceutical PreparationsIBA 01/2016 - 12/2014
2	Paraoxon (E600)IBA 08/2015 - 12/2014
2	dipropylacetamide (valpromide)IBA 02/2014 - 01/2012
1	Transcription Factors (Transcription Factor)IBA 10/2021
1	sulforaphaneIBA 10/2021
1	Potassium Channels (Potassium Channel)IBA 01/2019
1	omaveloxoloneIBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	CannabidiolIBA 01/2018
1	SolutionsIBA 01/2018
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2017
1	Cholinergic Agents (Cholinergics)IBA 12/2014
1	AmidesIBA 02/2014
1	CytokinesIBA 10/2013
1	Culture MediaIBA 10/2013
1	BenzodiazepinesIBA 08/2013
1	BicucullineIBA 01/2012

Therapy/Procedure

5	Therapeutics 01/2019 - 09/2013
1	Electrodes (Electrode) 12/2014